Quick Answer
Scinai Immunotherapeutics Ltd. reported Stockholders Equity of $9.98 million for the year ending 2024.
- Scinai Immunotherapeutics Ltd. showed an increase of +318.4% in Stockholders Equity from 2023 to 2024.
- This data is from Scinai Immunotherapeutics Ltd.'s annual report (Form 10-K), filed with the SEC on May 7, 2025.
- XBRL data for this metric is available from 2020 to 2024 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2022: -$862.0 thousand | Q1 2023: -$4.81 million.
- Over the full 5 years of available data (2020 to 2024), Scinai Immunotherapeutics Ltd.'s Stockholders Equity has grown by 166.3%.
- Historical annual values: Fiscal year 2024: $9.98 million | Fiscal year 2023: -$4.57 million | Fiscal year 2022: -$1.76 million | Fiscal year 2021: $982.0 thousand | Fiscal year 2020: -$15.04 million.
- Data sourced from SEC EDGAR public filings as of August 5, 2026.
Last verified: